Ideaya Biosciences Stock Alpha and Beta Analysis
| IDYA Stock | USD 18.58 0.38 2.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ideaya Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ideaya Biosciences over a specified time horizon. Remember, high Ideaya Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ideaya Biosciences' market risk premium analysis include:
Beta 0.37 | Alpha (0.42) | Risk 2.79 | Sharpe Ratio (0.19) | Expected Return (0.52) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ideaya |
Ideaya Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ideaya Biosciences market risk premium is the additional return an investor will receive from holding Ideaya Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ideaya Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ideaya Biosciences' performance over market.| α | -0.42 | β | 0.37 |
Ideaya Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ideaya Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Ideaya Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Ideaya Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Ideaya Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ideaya Biosciences shares will generate the highest return on investment. By understating and applying Ideaya Biosciences stock market price indicators, traders can identify Ideaya Biosciences position entry and exit signals to maximize returns.
Ideaya Biosciences Return and Market Media
The median price of Ideaya Biosciences for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 23.64 with a coefficient of variation of 11.28. The daily time series for the period is distributed with a sample standard deviation of 2.62, arithmetic mean of 23.19, and mean deviation of 2.17. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | IDEAYA Biosciences Secures Exclusive License for Promising DLL3-Targeting ADC, SHR-4849 | 12/30/2024 |
2 | IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 01/31/2025 |
3 | BlackRock, Inc.s Strategic Acquisition of IDEAYA Biosciences Inc Shares | 02/05/2025 |
4 | IDEAYA Biosciences Announces Appointment of Healthcare Investment Banking Veteran Joshua Bleharski as Chief Financial Officer | 02/10/2025 |
5 | IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | 02/13/2025 |
6 | Down -8.63 percent in 4 Weeks, Heres Why You Should You Buy the Dip in IDEAYA Biosciences | 02/14/2025 |
7 | Disposition of 12808 shares by Yujiro Hata of Ideaya Biosciences at 19.52 subject to Rule 16b-3 | 02/18/2025 |
8 | Acquisition by Yujiro Hata of 600000 shares of Ideaya Biosciences at 20.24 subject to Rule 16b-3 | 02/27/2025 |
9 | IDEAYA Biosciences Collaborates with ATTMOS to Revolutionize AIML-Enabled Drug Discovery | 03/03/2025 |
10 | Analysts Set IDEAYA Biosciences, Inc. Price Target at 53.58 | 03/06/2025 |
About Ideaya Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ideaya or other stocks. Alpha measures the amount that position in Ideaya Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2025 (projected) | Current Ratio | 11.68 | 19.65 | 9.62 | Net Debt To EBITDA | 1.08 | 1.18 | 0.19 |
Ideaya Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Ideaya Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ideaya Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ideaya Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ideaya Biosciences. Please utilize our Beneish M Score to check the likelihood of Ideaya Biosciences' management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Ideaya Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Ideaya Biosciences Backtesting, Ideaya Biosciences Valuation, Ideaya Biosciences Correlation, Ideaya Biosciences Hype Analysis, Ideaya Biosciences Volatility, Ideaya Biosciences History and analyze Ideaya Biosciences Performance. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Ideaya Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.